Is this your brand? Sign in to claim ownership.
Sign in to claim this brandAgilent Technologies Inc.
United States·US-MF-000009385
Last updated September 17, 2026
What Agilent Technologies Inc. makes
Agilent Technologies Inc. manufactures reagents and instruments for in vitro diagnostics, including nucleic acid hybridization detection kits, microplate washers, automated and semi-automated microplate readers, and electronic liquid dispensers for laboratory use. Their portfolio also includes immunohistochemical staining kits—such as DAB chromogen systems, reticulin, mucicarmine, and Giemsa stains—and mounting media for tissue samples. Negative control immunoglobulins and antibodies targeting melanosomes and cytokeratins are also part of their diagnostic offerings.
The company’s devices are regulated under EU Class A, I, II, and III classifications and are listed in the EUDAMED database and the FDA’s Unique Device Identifier (UDI) system. Agilent Technologies Inc. is headquartered in the United States.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Information
- Country
- United States
- Address
- 5301, Stevens Creek Blvd., Santa Clara, United States
- Website
- www.agilent.com
- —
- —
- [email protected]
- Phone
- +45 44859756
- PRRC Contact
- Grace Lee
- EUDAMED SRN
- US-MF-000009385
- FDA FEI Number
- 3009189893
- DUNS Number
- —
Catalogue (1184)
Page 18 of 24Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Recalls (5)
Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.
Agilent Technologies Inc. has five FDA recall records initiated between June 17, 2015, and March 20, 2025. The records include one classified, one open, and three terminated cases, with reasons involving software defects in LC/MS devices, missing 510(k) clearance for a marketed product, incorrect expiration dates on labels, a genetic component issue in a DNA labeling kit, and a potential structural failure in an automated slide processing system door.
AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.
| Date | Recall No. | Class | Status | Reason |
|---|---|---|---|---|
| Mar 20, 2025 | Z-1544-2025 | — | open, classified | DNA Labeling Kit for use in sample labeling to be hybridized to oligonucleotide microarrays has a component, Human Reference DNA Female aliquot, affected by a mosaic aberration that may result in Chromosome 12 baseline shift, which may lead to false positive/negative results, resulting in diagnosis delay, and may lead to delayed treatment of a treatable genetic disorder. |
| Apr 2, 2024 | Z-1919-2024 | — | open, classified | There is the potential for the front plexiglass door of the automated slide processing system to break causing potential injury. |
| May 20, 2022 | Z-1384-2022 | — | open, classified | Label provided for substrate vail contained incorrect expiration date. |
| Aug 15, 2018 | Z-2359-2019 | — | terminated | When utilizing specific software versions of an LC/MS device, and Batch at a Glance in Compound Table view, a defect occurs when a new sample(s) is inserted. This defect creates a mismatch between the sample name and the column header whereby the sample header will be offset by one sample. The recalling firm requests that you discontinue using this workflow to generate reports because the Quant batch table will not display fully analyzed results or save any changes made. |
| Jun 17, 2015 | Z-1737-2017 | — | terminated | The product was marketed without 510(k) clearance. |
FDA Establishments (1)
Establishments registered with the FDA under this company group, matched by name.
- Agilent Technologies Waldbronn Baden-Wurttemberg · DE FEI 3009202467